Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CYNATA-THERAPEUTICS-LIMIT-14942262/news/Treatment-Commences-in-Second-Patient-Cohort-in-Cynata-s-World-First-Clinical-Trial-25862068/?utm_source=whatsapp&utm_medium=social&utm_campaign=share